In the News

Recent Coverage of HMS in the News
May 1, 2013

The study of connective tissue is shedding light on pain and providing new explanations for alternative medicine. Helene M. Langevin, HMS visiting professor of medicine at Brigham and Women’s Hospital and director of the Osher Center for Integrative Medicine, authored the piece.

April 30, 2013

New, noninvasive blood-plasma based methods to follow the genetic and molecular evolution of solid tumors in patients are emerging. These technologies detect mutations in circulating tumor DNA, allowing monitoring of tumor changes over time. George D. Demetri, HMS professor of medicine at the Dana-Farber Cancer Institute, is one of the lead researchers.

April 30, 2013

HMS student Nathaniel P. Morris wrote this opinion piece about the importance of medical research.

April 29, 2013

A Boston psychiatrist wants the brain of slain marathon bomb suspect Tamerlan Tsarnaev studied like a crime scene to look for evidence that his boxing career may have left his brain damaged and possibly prone to depression and aggression. In an op-ed published in The Boston Globe, Michael Craig Miller, HMS assistant professor of psychiatry at Beth Israel Deaconess Medical Center, argued that neuroscientists should be given the chance to examine Tsarnaev's brain.

April 29, 2013

Forensic psychologists say there are a number of mental health conditions that could cause a young man — even one who is intelligent and seemingly well adjusted, as some acquaintances have described Dzhokhar Tsarnaev — to fall under the malicious influence of a father figure. Harold Bursztajn, HMS associate clinical professor of psychiatry at Beth Israel Deaconess Medical Center, is quoted.

April 29, 2013

While doctors and nurses can make mistakes with medications in hospitals, a new study says drug errors often happen at home and can lead to harm. Christopher Landrigan, HMS associate professor of medicine at Brigham and Women’s Hospital, wrote a commentary accompanying the new study.

April 29, 2013

Harvard University has received a $50 million gift from businessman and alumnus Len Blavatnik to support a major initiative aimed at bridging the “valley of death” — the gap between basic biomedical research and the emergence of new therapies for patients. Greg Verdine, the Erving Professor of Chemistry in the Department of Stem Cell and Regenerative Biology and of Chemistry and Chemical Biology at FAS, is quoted.

April 29, 2013

The Marathon bombings two weeks ago cast a bright spotlight not only on the courageous first responders, and volunteers at the scene, but also on the extraordinary people who work in health care in the Boston area. Beth Lown, HMS associate professor of medicine at Mount Auburn Hospital, was a co-author of this op-ed.

Pages